| 4 min read
Proteomic studies, billion dollar pharma deals, WHO initiatives, and more led the news this week.
| 6 min read
Alzheimer’s disease often overlaps with other causes of cognitive decline. A new proteomics project aims to untangle that mixture and help researchers identify the right patients for future clinical trials.
| 3 min read
Researchers showed that before cancer cells metastasize the brain, they enter a “proliferative pause” that can be targeted with drugs to prevent metastasis altogether.
| 3 min read
John Yu built Kairos Pharma on a simple bet: Cancer drugs don't fail, tumors just learn to outrun them.
| 2 min read
Phase 2b data for EloraTZP suggest the next gains in obesity will come from stacking hormone pathways, and that tolerability may decide who wins.News
| 4 min read
Pharma deals, regulatory updates, new treatments and more led the news this week.
| 3 min read
Scientists identified stem cells whose dysregulated calcium signaling drives the degenerative condition, opening the door to novel treatments.
| 4 min read
Antibody discovery is becoming less about finding the strongest binder and more about finding molecules that can survive the journey to the clinic.
| 4 min read
A new consortium will characterize 10,000 antibodies to a single standard, aiming to train AI models that flag manufacturing risks before candidates advance.
| 2 min read
In mice, the new drug led to recovery of motor function and vision by protecting nerve fibers and myelin.
| 2 min read
The next-generation tool, called Partita, identified both known and novel genes that contribute to resistance in lymphomas.
Cancer Research News
Imagene AI's quantitative pathology and CellCarta's CDx infrastructure offer biopharma sponsors one path from AI biomarker assay to regulatory submission
As 3D cell models advance toward mainstream use, the field must learn to work with biological variability rather than against it.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Expert insights on the ideas and innovations reshaping the field.
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.
